Acumed LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$21Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
5,271clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Acumed $16M associated (2023-2025)
- Osteomed $2.2M associated (2023-2025)
- Innate Implant $713K associated (2023-2025)
- Inframe Implant $397K associated (2023-2025)
- Ribloc $117K associated (2023-2025)
- Nanophix Implant $69K associated (2023-2025)
- Biobridge $48K associated (2023-2025)
- Arcphix System $13K associated (2023-2025)
- Acutie II $9,252 associated (2023-2025)
- Montage 5cc $9,108 associated (2023-2025)
- Dbm Putty $3,311 associated (2023-2025)
- Accuplate Patient-Specific Plate $3,181 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Shawn O'Driscoll | Rochester, MN | Orthopaedic Surgery | $10,300,030.38 |
| Marc Richard | Durham, NC | Orthopaedic Surgery | $370,552.82 |
| Melvin Rosenwasser | New York, NY | Surgery of The Hand (Surgery) | $326,290.92 |
| Roy Sanders | Temple Terrace, FL | Orthopaedic Surgery | $305,974.54 |
| Robin Kamal | Stanford, CA | Hand Surgery | $299,944.76 |
| Bruce Ziran | Lawrenceville, GA | Orthopaedic Trauma | $277,855.53 |
| William Geissler | Jackson, MS | Hand Surgery | $271,790.64 |
| Randipsingh Bindra | Maywood, IL | Hand Surgery | $259,625.52 |
| Jerry Huang | Seattle, WA | Hand Surgery | $207,459.34 |
| Selene Parekh | Bensalem, PA | Orthopaedic Surgery | $203,353.02 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.